Drug Detail
Information about Anlotinib
Generic Name |
Anlotinib | |
|---|---|---|
IND |
AL3818 | |
Brand Name (US) |
||
Manufacturer |
Advenchen Laboratories | |
Drug Type |
Kinase inhibitor | |
Delivery |
Oral | |
Approval Status |
Phase 3 | |
Indications |
NSCLC, CRC | |
Overall Strategy |
KIT Protein Based + Oncogenic Signal Path Based | |
Strategy |
Block KIT + Block related tumor signal paths | |
Drug Category |
KIT + VEGFR | |
Search for this drug/combination in: